Use the same data
Supply compounds, salts, stereochemical edge cases, reactions, targets, assay results and legacy identifiers to both vendors.
Short answer
Choose Adroit for evaluation when the priority is a connected chemistry-and-biology model, chemistry-aware search, flexible private deployment, a CRO or customer portal, or a deliberately scoped implementation. Choose Dotmatics for evaluation when the requirement is a broad established portfolio including an ELN and multiple specialist applications across scientific disciplines.
Important: this comparison is published by Adroit. Product packaging and capabilities change, so buyers should verify current requirements with both suppliers and run the same representative data and workflows in each evaluation.
Capability and buying-model comparison
| Evaluation area | Adroit | Dotmatics |
|---|---|---|
| Primary proposition | Unified chemistry and biology data platform connecting molecules, targets, reactions and assays. | Broad end-to-end scientific R&D portfolio spanning data management and specialist applications. |
| Chemical registration and search | Compound registration plus exact, substructure and Tanimoto similarity search with stereochemistry controls. | Entity registration includes chemical structures, samples and a broad range of biological entities. |
| Biology | Protein registration, sequences, variants, isoforms, targets, HELM entities and linked assay context. | Registration supports DNA, RNA, peptides, proteins, antibodies, conjugates, plasmids, cell lines and user-defined entities. |
| ELN | Adroit is a scientific data platform that can sit alongside an existing ELN or be configured around the selected workflow. | Dotmatics markets a dedicated ELN and Data Discovery platform. |
| Deployment | Cloud, on-premises, hybrid and air-gapped options are explicitly offered. | Buyers should confirm the current deployment and operating model for every required Dotmatics component. |
| Implementation approach | Starts with the priority workflow, representative data, integrations and governance constraints. | Broader application coverage may suit programmes seeking a larger R&D software portfolio; scope and dependencies should be tested during evaluation. |
| Best evaluation fit | Biotech, pharma and CRO teams needing connected discovery data, private deployment or a white-label portal. | Organisations seeking broad scientific application coverage, dedicated ELN functionality or multiple specialist tools. |
Questions to test in both products
Trace the relationships
Ask each system to move from a compound through batch, reaction, target and assay evidence without spreadsheet reconciliation.
Test deployment reality
Request an architecture covering identity, networking, backups, updates, integrations and operational ownership.
Measure total effort
Separate licence, configuration, migration, validation, training, integration and internal administration effort.
Evidence used for this comparison
Adroit capability descriptions are drawn from the Adroit platform page, compound registration page and deployment page. Dotmatics descriptions are drawn from its official end-to-end R&D solution, entity registration and ELN pages, reviewed on 30 September 2026.
Neither supplier's marketing page substitutes for a technical evaluation. Ask both suppliers to demonstrate the difficult cases using the same acceptance criteria.